September 2022
1. DESEKE M, Rampoldi F, Sandrock I, Borst E, et al
   A CMV-induced adaptive human Vdelta1+ gammadelta T cell clone recognizes HLA-DR.
   J Exp Med. 2022;219.
   

   >> Share

   
   August 2021
2. MA S, Yan J, Barr T, Zhang J, et al
   The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity.
   J Exp Med. 2021;218.
   

   >> Share

   
   May 2021
3. KVESTAK D, Juranic Lisnic V, Lisnic B, Tomac J, et al
   NK/ILC1 cells mediate neuroinflammation and brain pathology following congenital CMV infection.
   J Exp Med. 2021;218.
   

   >> Share

   
   April 2021
4. SHEPPARD S, Sun JC
   Virus-specific NK cell memory.
   J Exp Med. 2021;218.
   

   >> Share

   
   April 2020
5. WIEDUWILD E, Girard-Madoux MJ, Quatrini L, Laprie C, et al
   beta2-adrenergic signals downregulate the innate immune response and reduce host resistance to viral infection.
   J Exp Med. 2020;217.
   

   >> Share

   
   
6. DIAZ-SALAZAR C, Bou-Puerto R, Mujal AM, Lau CM, et al
   Cell-intrinsic adrenergic signaling controls the adaptive NK cell response to viral infection.
   J Exp Med. 2020;217.
   

   >> Share

   
   March 2020
7. LUBKE M, Spalt S, Kowalewski DJ, Zimmermann C, et al
   Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models.
   J Exp Med. 2020;217.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share